We have developed award-winning NANOPLEX™ technology for rapid identification and enumeration of bacterial pathogens.
NANOPLEX™ can support clinicians to achieve same-day-decision consultations; reducing turn-around-times from 48 hours to 15 minutes with simple and easy to use bacterial testing. GPS is 200x faster than conventional diagnostics and quantitatively detects bacteria in a 6-log dynamic range.
Bacteria are identified by proprietary nano-material labels which are then identified using an advanced optical measurement system, in a simple 3 step process.
FluoretiQs QPS toolkit is an optical measurement platform with the flexibility to perform fluorescence or absorption measurements with simultaneous photon counting and spectroscopy. Get in touch to discuss how our QPS toolkit can support your research.
“Around 700,000 people around the world die annually due to drug-resistant infections. If no action is taken, it has been estimated that drug-resistant infections will kill 10 million people a year by 2050”
-Dame Sally Davies, UK Chief Medical Officer (AMR review)
FluoretiQ was founded to respond to the steadily growing threat of antibiotic resistance with an intuitive diagnostic that redefines pathology testing 200x faster in simple 3-step process.
Based at the UnitDX biosciences hub in the heart of Bristol, FluoretiQ are thriving in a recognised European City of Innovation.